Much more than giving back, Root of Skin™ MD’s mission fuels a collective, unwavering devotion to advancements in cancer care.
The team behind Root of Skin™ MD live for what they do and love doing it. They are world leaders in regenerative medicine, pioneering life-changing cancer therapies.
At the helm of Root of Skin™ MD is Dr. Hans Keirstead, a world-renowned stem cell expert and entrepreneur who has led the development of therapies for late stage cancers, immune disorders, motor neuron diseases, spinal cord injury and retinal diseases.
Hans continually looks to extend the team’s expertise in stem cell science into new therapies. When he proposed developing a truly regenerative skincare brand as a source of funding for AIVITA Biomedical’s cancer research programs, the entire team was immediately on board.
About AIVITA Biomedical
AIVITA Biomedical is a Biotechnology company designing personalized vaccines that target the source of all cancers: tumor-initiating cells. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its therapeutic pipeline.
AIVITA’s lead focus is on a patient-specific immunotherapy for the treatment of advanced cancers. Our treatments direct the patient’s own immune system to seek out and destroy the very cells responsible for the growth and spread of the disease. Based on clinical trial results showing tremendous promise in eradicating tumors without harmful side effects, the technology is the subject of two US-based Phase 2 clinical trials for ovarian cancer and glioblastoma, and a Phase 1B trial in Melanoma.